Sekundärprophylaxe der venösen Thromboembolie

Schlüsselwörter

tiefe Venenthrombose - Lungenarterienembolie - venöse Thromboembolie - Antikoagulation - Sekundärprophylaxe

Keywords

deep vein thrombosis - pulmonary embolism - venous thromboembolism - anticoagulation - secondary prevention

• Literatur

• 1 Baglin T, Douketis J, Tosetto A et al. Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. J Thromb Haemost 2010; 8: 2436-2442
• 2 Bauersachs R, Berkowitz SD, Brenner B et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010; 363: 2499-2510
• 3 Hach-Wunderle V (Leitlinienkoordination). Interdisziplinäre S2: Leitlinie: Diagnostik und Therapie der Bein- und Beckenvenenthrombose und der Lungenembolie. VASA 2010; 39: S/78
• 4 Kearon C, Akl E, Comerota AJ et al. Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e419S-e494S
• 5 Kearon C. Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated. J Thromb Thrombolysis 2011; 31: 295-300
• 6 Taliani MR, Becattini C, Agnelli G et al. Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities. Thromb Haemost 2009; 101: 596-598
• 7 Tan M, Mos IC, Klok FA et al. Residual venous thrombosis as predictive factor for recurrent venous thromboembolism in patients with proximal deep vein thrombosis. Br J Haematol 2011; 153: 168-178
• 8 Tosetto A, Iorio A, Marcucci M et al. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost 2012; 10: 1019-1025